LENZ – lenz therapeutics, inc. (US:NASDAQ)
Stock Stats
News
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ™) in South Korea for the Treatment of Presbyopia
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
LENZ Therapeutics to Present at Upcoming Investor Conferences
LENZ Therapeutics (NASDAQ:LENZ) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Insider Spends US$239k Buying More Shares In LENZ Therapeutics [Yahoo! Finance]
Form 4 LENZ Therapeutics, Inc. For: Nov 17 Filed by: Olsson Shawn
Form 144 LENZ Therapeutics, Inc. Filed by: Olsson Shawn
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Paradigm Biocapital Advisors LP
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.
Form SCHEDULE 13D/A LENZ Therapeutics, Inc. Filed by: Versant Venture Capital VI, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.